Immunology company Agenus Inc. has acquired XOMA Corporation’s antibody pilot plant manufacturing facility and antibody technology capabilities for $6 million. Additionally, Agenus obtained an exclusive license to a phage display library from IONTAS, and entered into an agreement for cell line development technology with Selexis. The company says these new capabilities, in combination with its Retrocyte Display and SECANT yeast display platforms, will result in a broad, vertically integrated in-...